Becker's Healthcare September 13, 2024
Tampa, Fla.-based Moffitt Cancer Center and drugmaker AstraZeneca are collaborating to accelerate the development of CAR-T cell and T cell receptor therapies.
“We are excited to collaborate with AstraZeneca to push the boundaries of what’s possible in cancer treatment,” Patrick Hwu, MD, Moffitt’s president and CEO, said in a Sept. 13 news release. “By combining our clinical expertise with AstraZeneca’s...